David Gómez-Almaguer
Universidad Autónoma de Nuevo León
401 Papers
1.3K Citations
David Gómez-Almaguer is an academic researcher from Universidad Autónoma de Nuevo León. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 30, co-authored 309 publications.
Chat about Author
Papers
•Journal Article
Efecto sobre los niveles de moléculas de adhesión endotelial (sVCAM-1, sICAM-1 y sE-selectina) después del tratamiento con filgrastim o molgramostim en pacientes con neutropenia posquimioterapia o radioterapia
Oscar González-Llano,Laura Nely-Rodríguez,Mario Fredy-Sandoval,Hugo Castro-Rodríguez,Aarón Molina-Pérez,Jorge Revilla-Beltri,Álvaro Gómez-Peña,David Gómez-Almaguer +7 more
TL;DR: The same biological effect of three different CSF on the adhesion molecules was observed regardless of the type of G- CSF or GM-CSF used, and there were no differences in the safety of these drugs during the treatment of patients with chemotherapy associated neutropenia.
Transient mixed chimerism after stem cell transplantation can induce durable molecular complete remissions in chronic myelogenous leukemia.
TL;DR: It is possible that the transient induction of a graft-vs-leukemia effect was able to control the malignancy despite the fact that the three patients lost the graft; however, other possible explanations are discussed.
Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible.
Perla R. Colunga-Pedraza,Andrés Gómez-De León,Carlos Saúl Rodríguez-Roque,Michelle Morcos-Sandino,Julia E. Colunga-Pedraza,Olga G. Cantú-Rodríguez,César Homero Gutiérrez-Aguirre,David Gómez-Almaguer +7 more
- 01 Mar 2021
TL;DR: In this article, the feasibility and safety of an outpatient haplo-HSCT on an outpatient basis was evaluated in a single center, retrospective cohort, n=60 adult patients undergoing HaploHSCT.
Mobilization kinetics of CD34+ hematopoietic stem cells stimulated by G-CSF and cyclophosphamide in patients with multiple sclerosis who receive an autotransplant
José Carlos Jaime-Pérez,Ana Cristina Gómez-Galaviz,Grecia A. Turrubiates-Hernández,Ernesto Picón-Galindo,Rosario Salazar-Riojas,Nereida Méndez-Ramírez,David Gómez-Almaguer +6 more
TL;DR: Mobilization with G-CSF and Cy in MS patients resulted in effective CD34+ hematoprogenitors release from the bone marrow and in intra-apheresis recruitment.
Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial
Consuelo Mancías-Guerra,Alma Rosa Marroquín-Escamilla,Oscar González-Llano,Laura Villarreal-Martínez,José Carlos Jaime-Pérez,Fernando García-Rodríguez,Sagrario Lisete Valdés-Burnes,Laura Nely Rodríguez-Romo,Dinorah Catalina Barrera-Morales,José Javier Sánchez-Hernández,Olga G. Cantú-Rodríguez,César Homero Gutiérrez-Aguirre,Andrés Gómez-De León,Guillermo Elizondo-Riojas,Rosario Salazar-Riojas,David Gómez-Almaguer +15 more
TL;DR: Subarachnoid placement of autologous bone marrow-derived total nucleated cell (TNC) intrathecal and intravenous injection after stimulation with granulocyte colony-stimulating factor in children with CP is a safe procedure and suggests a possible increase in neurological function.